Today's special offer: Access for Free!!!

Pfizer Inc. (PFE) | Income Statement

See also

ˇ Show More

The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

You have visited 10 password protected pages for free. Others contain data covered by .

Sign Up Now to get full access to whole website and cut out all advertisements.

Pfizer Inc., Consolidated Income Statement

USD $ in millions

Export to Excel Export to OpenOffice.org
  12 months ended Dec 31, 2011 Dec 31, 2010 Dec 31, 2009 Dec 31, 2008 Dec 31, 2007
chart Revenues
chart Cost of sales
chart Gross profit
chart Selling, informational and administrative expenses
chart Research and development expenses
chart Amortization of intangible assets
chart Acquisition-related in-process research and development charges
chart Restructuring charges and certain acquisition-related costs
chart Royalty-related income
chart Net gain (loss) on asset disposals
chart Certain legal matters, net
chart Certain asset impairment charges
chart Gain related to ViiV
chart Other, net
chart Other income (expense), net
chart Operating income
chart Interest income
chart Interest expense
chart Net interest income (expense)
chart Income from continuing operations before provision for taxes on income
chart Provision for taxes on income
chart Income from continuing operations
chart Discontinued operations, net of tax
chart Net income before allocation to noncontrolling interests
chart Net income attributable to noncontrolling interests
chart Net income attributable to Pfizer Inc.
Source: Pfizer Inc., Annual Reports
Item Description The company
Revenues Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Pfizer Inc.'s revenues increased from 2009 to 2010 but then slightly declined from 2010 to 2011.
Operating income The net result for the period of deducting operating expenses from operating revenues. Pfizer Inc.'s operating income declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level.
Income from continuing operations before provision for taxes on income Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Pfizer Inc.'s income from continuing operations before provision for taxes on income declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level.
Income from continuing operations This represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Pfizer Inc.'s income from continuing operations declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level.
Net income before allocation to noncontrolling interests The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Pfizer Inc.'s net income before allocation to noncontrolling interests declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level.
Net income attributable to Pfizer Inc. The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Pfizer Inc.'s net income attributable to Pfizer Inc. declined from 2009 to 2010 but then increased from 2010 to 2011 exceeding 2009 level.

Top

Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center